Article Text

Download PDFPDF
Systemic inhibition of extracellular signal-regulated kinase (ERK) has a protective effect in neonatal cerebral white matter injury
  1. L Thei1,
  2. M Hristova1,
  3. G Kendall1,
  4. D Peebles1,
  5. F Miller2,
  6. D Kaplan2,
  7. G Raivich1
  1. 1Perinatal Brain Repair Group, Institute for Women's Health, University College London, London, UK
  2. 2University of Toronto, Toronto, Canada


The extracellular signal-regulated kinase (ERK) cascade, a key component of mitogen-activated protein kinase signalling, is important in synaptic plasticity, in mediating mitogenic and trophic effects, as well as for cell proliferation in normal and transformed non-neuronal cells. Here, we explored phosphorylated ERK immunoreactivity (pERK-IR) following hypoxic-ischaemic (HI) insult in postnatal day 7–8 mice (equivalent to approx 31–32 week human gestation) by unilateral carotid artery occlusion, followed by hypoxia (8% O2/N2).

Exposure to 30 min HI resulted in massive increase in forebrain pERK-IR followed by strong white matter (WM) damage, but only mild involvement of the overlying cortical grey matter. Mapping for activated pERK revealed a time-clock sequence of cellular events, beginning with periventricular WM axons (15–45 min post HI onset), followed by white and grey matter glia and cortical neurons (1–4 h post HI onset), returning to normal by 8 h. Systemic inhibition of MEK1/2 with SL327 resulted in significant decrease in WM damage. This could point to activated MEK1/2 and ERK as promising targets for therapeutic intervention in neonatal brain damage, and in prevention of periventricular leukomalacia.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.